🧘
Google: new treatment approved4h ago
FDA Approves Bysanti for Bipolar 1 and Schizophrenia
The FDA just approved a new treatment option for people living with bipolar 1 disorder and schizophrenia.
Bysanti offers fresh hope for millions managing these challenging mental health conditions.
Want to know more?
1/4